UAE Contraceptive Devices Market Report 2022 to 2030

UAE Contraceptive Devices Market Analysis

$ 3999

UAE's Contraceptive Devices Market is expected to witness growth from $65 Mn in 2022 to $129 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-30. In the UAE, particularly among young people, there is a high frequency of STDs. Because of this, there is an increased need for barrier methods of contraception like condoms, which is boosting the market for contraceptive manufacturers. The market is segmented by type and by gender. Some key players in this market include Julphar Life, Neopharma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10AEMD005 CATEGORY: Medical Devices GEOGRAPHY: UAE AUTHOR: Jigyasu Bhandari

Buy Now

UAE Contraceptive Devices Healthcare Market Executive Analysis

UAE's Contraceptive Devices Market is expected to witness growth from $65 Mn in 2022 to $129 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-30. Healthcare costs in the UAE are currently $2,996.36 per person, up from $2,843.78 in 2018. The UAE's GDP will include 5.5% of healthcare spending in 2021. Male and female life expectancy rates in the UAE are 78.21 and 80.99 years, respectively, in 2022.

In UAE, approximately 1.5 fatalities per 100,000 live births is the UAE's extremely low maternal mortality rate. A reported 33 instances of syphilis, 410 cases of chlamydia, and 514 cases of gonorrhea were recorded in 2021, reflecting a significant decline in the incidence of STDs in the UAE. To avoid unexpected births, contraceptive devices are utilized, and they can be a very useful tool for people and couples in the UAE who want to limit their fertility. Contraceptive methods are primarily used to avoid unplanned pregnancies. This can provide individuals and couples with more control over their fertility and enable them to decide when to start a family with knowledge. Contraceptive methods can lessen the need for abortions by preventing unplanned pregnancies. This can lessen hazards and difficulties while also enhancing reproductive health outcomes for women in the UAE.

UAE Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In the UAE, particularly among young people, there is a high frequency of STDs. Because of this, there is an increased need for barrier methods of contraception like condoms, which is boosting the market for contraceptive manufacturers. People in the UAE have a lot of discretionary income and are eager to spend it on high-quality medical care. Due to the rise in demand for effective and high-quality contraceptives, the market is now offering chances to makers. In order to lower the birth rate in the nation, the UAE government actively promotes family planning through a number of programmes, such as the National Strategy for Population Growth. The increased demand for contraceptive methods as a result of these activities has given producers in the industry room to develop.

Market Restraints

Many residents of the UAE might not be familiar with the various kinds of contraceptive methods that are available or may not fully comprehend how to use them. The demand for these products may decline as a result of this lack of knowledge. Since the UAE is a conservative Muslim nation, several kinds of contraception can be viewed as being improper from a cultural or religious standpoint. Certain forms of contraceptives may be difficult for manufacturers to market and sell in the UAE. It's possible that not all areas of the UAE, particularly in the countryside, have access to contraceptive devices. Effective product distribution for producers may become challenging as a result.

Competitive Landscape

Key Players

Julphar Life (UAE)
Neopharma (UAE)
Al Ittihad Drug (UAE)
Mylan Laboratories
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

The United Arab Emirates (UAE) has an effective framework for regulating contraceptive devices. The Emirates Authority for Standardisation and Metrology (ESMA) is responsible for regulating contraceptive devices in the UAE. In the UAE, ESMA is in charge of medical device registration, testing, and approval. Condoms, intrauterine devices, and oral contraceptives account for the majority of the market share in the UAE for contraceptive devices. Regulations that control their production, importation, distribution, and sale apply to these goods. To offer health insurance coverage to all nationals and foreigners of the UAE, the government of the UAE introduced the National Health Insurance Scheme (NHIS) in 2020. Family planning and contraceptive services are included in the NHIS's list of preventative, curative, and rehabilitation services. The UAE government also runs a network of medical facilities where residents and citizens can get contraceptives and family planning services. These clinics must adhere to stringent rules and specifications because they are governed by the Ministry of Health and Prevention (MoHAP).

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.